These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780 [TBL] [Abstract][Full Text] [Related]
7. [What the nephrologist should know about antiphospholipid syndrome?]. Heleniak Z; Zdrojewski Z; Rutkowski B Pol Merkur Lekarski; 2009 Mar; 26(153):215-9. PubMed ID: 19388535 [TBL] [Abstract][Full Text] [Related]
8. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574 [TBL] [Abstract][Full Text] [Related]
9. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471 [TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Asherson RA; Cervera R; Merrill JT; Erkan D Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305 [TBL] [Abstract][Full Text] [Related]
11. [Antiphospholipid syndrome and kidney]. Roccatello D; Rossi D; Giachino O; Bazzan M; Mazzucco G G Ital Nefrol; 2007; 24(2):111-20. PubMed ID: 17458826 [TBL] [Abstract][Full Text] [Related]
12. Thrombosis of vascular access associated with factor V Leiden, antiphospholipid antibodies and antiheparin antibodies in a young woman on dialysis receiving warfarin following mitral valve replacement. Molino D; De Lucia D; Perna AF; Cirillo M; De Santo NG Nephrol Dial Transplant; 2006 Jun; 21(6):1719-20. PubMed ID: 16476715 [No Abstract] [Full Text] [Related]
13. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect? Ravandi-Kashani F; Cortes J; Talpaz M; Kantarjian HM Cancer; 1999 Jun; 85(12):2583-8. PubMed ID: 10375106 [TBL] [Abstract][Full Text] [Related]
14. Reversible renal failure due to the antiphospholipid antibody syndrome, pre-eclampsia and renal thrombotic microangiopathy. Kon SP; Kwan JT; Raftery MJ Clin Nephrol; 1995 Oct; 44(4):271-3. PubMed ID: 8575129 [TBL] [Abstract][Full Text] [Related]
15. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency. Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529 [TBL] [Abstract][Full Text] [Related]
16. [Appearance of antiphospholipid antibodies in patients with hepatitis C treated with interferon-alpha]. Doutre MS; Baquey A; Bernard P; Couzigou P; Bernard N; Lacoste D; Morlat P Ann Med Interne (Paris); 1997; 148(1):99-100. PubMed ID: 9137700 [No Abstract] [Full Text] [Related]
17. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses. Sanmarco M; Alessi MC; Harle JR; Sapin C; Aillaud MF; Gentile S; Juhan-Vague I; Weiller PJ Thromb Haemost; 2001 May; 85(5):800-5. PubMed ID: 11372671 [TBL] [Abstract][Full Text] [Related]